AKT1 and cancer: The results showed that TMQ activated modulating immune factors, and oxidative stress, activated the cancer transcriptional deregulation pathways, inhibited the cholinergic synapses, the AMPK and PI3K/Akt/mTOR signaling pathways, thus exhibiting antitumor activity.